Pharmacy technology of the ICU: Today and tomorrow

Critical Care Clinics

Volumn 16, Issue 4, 2000, Pages 641-658

  Mann, Henry J ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AZITHROMYCIN; CISAPRIDE; DILTIAZEM; FAMOTIDINE; HUMAN INSULIN; LAMIVUDINE; NIFEDIPINE; OMEPRAZOLE; PACLITAXEL; PAROXETINE; PRAVASTATIN; RECOMBINANT ERYTHROPOIETIN; SALBUTAMOL;

BIOTECHNOLOGY; COST CONTROL; DRUG INDUSTRY; DRUG INFORMATION; INTENSIVE CARE UNIT; PATIENT CARE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; REVIEW; TECHNOLOGY;

EID: 0033735757     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(05)70138-X     Document Type: Article

References (24)

1. Telemedicine and telepharmacy: Current status and future implications
2. The costs of adverse drug events in hospitalized patients
3. Incidence of adverse drug events and potential adverse drug events: Implications for prevention
4. The healthcare costs of drug related morbidity and mortality in nursing facilities
5. Biosynthesis, Combinatorially
6. Microchip systems of immunoassay: An integrated immunoreactor
7. Downsizing chemistry
8. Drug related morbidity and mortality: A cost of illness model
9. Pharmacists participation on physician rounds and adverse drug events in the intensive care unit
10. Pharmaceutical agents in the year 2010
11. Biocatalysis grows for drug synthesis
12. Battling for blockbusters
13. Let there be light and let it heal
14. Counting on chiral drugs
15. Deciphering diseases
16. Drug producers have strong start for 1999
17. Drug producers post increased sales, earning